Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.

Clinical trial NCT00551473 · COMPLETED

Trial details

NCT number: NCT00551473
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease Reflux, Gastroesophageal

Start date: 2007-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.